4/A: CME Group Executive Amends Stock Sale Price

CME Group's Senior MD General Counsel, Jonathan L. Marcus, filed an amended Form 4 to correct the reported sale price of 3,291 shares of common stock.

Summary

• Jonathan L. Marcus, Senior MD General Counsel of CME Group Inc., filed an amended Form 4 (Form 4/A).
• The amendment corrects a clerical error in the price per share of common stock sold on March 17, 2026.
• The original Form 4 was filed on March 19, 2026.
• The corrected sale price for 3,291 shares of Common Stock Class A is $313.37 per share.
• The transaction was executed pursuant to a Rule 10b5-1 plan adopted by Mr. Marcus on February 18, 2025.
• Following the reported transaction, Mr. Marcus beneficially owns 7,192 shares of Common Stock Class A directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It is a routine amendment to correct a clerical error in a previously reported insider transaction and does not reflect new operational or financial performance information.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The amendment is being filed to correct the price per share of the common stock sold on March 17, 2026, which was incorrectly reported on the original Form 4 due to a clerical error.

Industry Context

StockSavvy.ai notes that Form 4/A filings are routine for correcting minor clerical errors in insider transaction reports, ensuring accuracy in public disclosures of executive stock movements. Such amendments are a standard part of regulatory compliance.

Stakeholder Impact

• Shareholders: Provides accurate disclosure of an executive's stock transaction, enhancing transparency regarding insider holdings.

Key Dates

Keywords

CME Group, Insider Transaction, Form 4/A, Stock Sale, Executive, Beneficial Ownership, 10b5-1 Plan, Clerical Error